These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19118520)

  • 1. Thiazolidinediones inhibit REG Ialpha gene transcription in gastrointestinal cancer cells.
    Yamauchi A; Takahashi I; Takasawa S; Nata K; Noguchi N; Ikeda T; Yoshikawa T; Shervani NJ; Suzuki I; Uruno A; Unno M; Okamoto H; Sugawara A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):743-8. PubMed ID: 19118520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.
    Sekikawa A; Fukui H; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T
    Carcinogenesis; 2008 Jan; 29(1):76-83. PubMed ID: 18024479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer.
    Sekikawa A; Fukui H; Fujii S; Nanakin A; Kanda N; Uenoyama Y; Sawabu T; Hisatsune H; Kusaka T; Ueno S; Nakase H; Seno H; Fujimori T; Chiba T
    Gut; 2005 Oct; 54(10):1437-44. PubMed ID: 15914572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells.
    Usami S; Motoyama S; Koyota S; Wang J; Hayashi-Shibuya K; Maruyama K; Takahashi N; Saito H; Minamiya Y; Takasawa S; Ogawa J; Sugiyama T
    Biochem Biophys Res Commun; 2010 Jan; 392(1):4-8. PubMed ID: 20056108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
    Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
    Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
    Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
    Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
    Betz MJ; Shapiro I; Fassnacht M; Hahner S; Reincke M; Beuschlein F;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3886-96. PubMed ID: 15886257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
    Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REG Ialpha protein expression in Barrett's esophagus.
    Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
    Smith AG; Beaumont KA; Smit DJ; Thurber AE; Cook AL; Boyle GM; Parsons PG; Sturm RA; Muscat GE
    Int J Biochem Cell Biol; 2009 Apr; 41(4):844-52. PubMed ID: 18822385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
    Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients.
    Hayashi K; Motoyama S; Sugiyama T; Izumi J; Anbai A; Nanjo H; Watanabe H; Maruyama K; Minamiya Y; Koyota S; Koizumi Y; Takasawa S; Murata K; Ogawa J
    Ann Surg Oncol; 2008 Apr; 15(4):1224-31. PubMed ID: 18259819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo.
    Kim SW; Choi OK; Chang MS; Shin CS; Park KS; Kim SY
    Biochem Biophys Res Commun; 2008 Jun; 371(2):197-202. PubMed ID: 18423377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-cancer action by PPARgamma ligand].
    Okumura T
    Nihon Rinsho; 2010 Feb; 68(2):267-72. PubMed ID: 20158095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer.
    Sekikawa A; Fukui H; Fujii S; Takeda J; Nanakin A; Hisatsune H; Seno H; Takasawa S; Okamoto H; Fujimori T; Chiba T
    Gastroenterology; 2005 Mar; 128(3):642-53. PubMed ID: 15765400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the IL-22/REG Ialpha axis in ulcerative colitis.
    Sekikawa A; Fukui H; Suzuki K; Karibe T; Fujii S; Ichikawa K; Tomita S; Imura J; Shiratori K; Chiba T; Fujimori T
    Lab Invest; 2010 Mar; 90(3):496-505. PubMed ID: 20065946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
    Chung SS; Kim JH; Park HS; Choi HH; Lee KW; Cho YM; Lee HK; Park KS
    Biochem Biophys Res Commun; 2008 Aug; 372(4):713-8. PubMed ID: 18513490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.